THE CHALLENGE
—Tackling the Pre-Clinical Experiments to Overcome Drug Resistance
Many patients with melanoma, papillary thyroid tumors, serous ovarian tumors, and colorectal tumors, for example, have DNA mutations that hyperactivate the major cell growth and survival pathway Ras/Raf/MEK/ERK, causing abnormal growth and cancer.
Unfortunately, patients…
